We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Lipid Nanoprobe Method Enables Rapid Isolation of Extracellular Vesicles

By LabMedica International staff writers
Posted on 25 Apr 2017
Print article
Image: Lipid nanoprobes (blue, green, and yellow colored) spontaneously insert themselves into lipid bilayer of three extracellular vesicles. The cargo content of extracellular vesicles includes proteins, DNA, and RNA. The lipid nanoprobe-labeled extracellular vesicles are captured onto the surface of a magnetic bead (black, bottom) through interaction with conjugated avidin molecules (red) (Photo courtesy of Xin Zou / Pennsylvania State University).
Image: Lipid nanoprobes (blue, green, and yellow colored) spontaneously insert themselves into lipid bilayer of three extracellular vesicles. The cargo content of extracellular vesicles includes proteins, DNA, and RNA. The lipid nanoprobe-labeled extracellular vesicles are captured onto the surface of a magnetic bead (black, bottom) through interaction with conjugated avidin molecules (red) (Photo courtesy of Xin Zou / Pennsylvania State University).
A novel method reduces the amount time required to isolate extracellular vesicles (EVs) from culture media or blood plasma from hours to 15 minutes and does not require bulky or expensive equipment.

EVs, which include exosomes, microvesicles, and apoptotic bodies, are cell-derived lipid-bilayer-enclosed structures, with sizes ranging from 30 to 5,000 nanometers. In the past decade, EVs have emerged as important mediators of cell communication because they serve as vehicles for the intercellular transmission of biological signals (proteins or nucleic acids) capable of altering cell function and physiology. In particular, exosomes (EVs with diameters of 30 to 150 nanometers) containing cell and cell-state specific proteins and nucleic acids are secreted by many cell types and have been identified in diverse body fluids. Growing evidence indicates that nanoscale EVs (nEVs) can regulate tumor immune responses, initiate formation of the pre-metastatic niche, determine organotropic metastasis, and contribute to chemotherapeutic resistance. nEVs are thus potential targets for therapeutic intervention in cancer.

While it is highly desirable to isolate nEVs rapidly for downstream molecular analyses, approaches reported for the isolation of nEVs - such as ultracentrifugation, immunoisolation, polymer-based precipitation, and filtration - involve lengthy protocols and can lead to impurities and nEV damage.

Investigators at Pennsylvania State University have developed a new technique to expedite isolation of nEVs. This lipid nanoprobe (LNP) system involves the labelling of the lipid bilayer of nEVs with biotin-tagged 1,2-distearoyl-sn-glycero-3-phosphethanolamine-poly(ethylene glycol) (DSPE–PEG). The labelled nEVs are then collected by NeutrAvidin (NA)-coated magnetic sub-micrometer particles (MMPs), for subsequent extraction and analyses of nEV cargo.

Compared with differential centrifugation (the most prevalent method for nEV isolation), the LNP shortens the isolation procedure from hours to 15 minutes and does not require bulky or expensive equipment. It is also highly flexible and can be adopted for various downstream analyses of DNA, RNA, and proteins.

The investigators reported in the April 10, 2017, online edition of the journal Nature Biomedical Engineering that they had applied the LNP method to obtain nEV DNA from 19 stage-IV non-small-cell lung-cancer (NSCLC) patients. Analyses of the contents of the nEVs allowed the detection of mutations in KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homologue) codons 12 and 13 and EGFR (epidermal growth factor receptor) exons 19 and 21.

“We invented a system of two micro/nano materials,” said senior author Dr. Si-Yang Zheng, associate professor of biomedical engineering and electrical engineering at Pennsylvania State University. “One is a labeling probe with two lipid tails that spontaneously insert into the lipid surface of the extracellular vesicle. At the other end of the probe we have a biotin molecule that will be recognized by an avidin molecule we have attached to a magnetic bead. Most cells generate and secrete extracellular vesicles, but they are difficult for us to study. They are sub-micrometer particles, so we really need an electron microscope to see them. There are many technical challenges in the isolation of nanoscale EVs that we are trying to overcome for point-of-care cancer diagnostics.”

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.